Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Crystallins are the major structural proteins of the vertebrate eye lens, essential for its transparency and refractive properties[4][2][9]. There are three main types: α-crystallin (a small heat shock protein with chaperone activity), β-crystallin, and γ-crystallin (both predominantly structural)[2][7][9]. Within these proteins, disulfide bonds—covalent links between sulfur atoms of cysteine residues—play a crucial role in stabilizing protein structure[1][3][5]. Recent research indicates that disulfide bonds can form during protein biosynthesis, not just as a post-translational modification[1]. In the aging lens or under oxidative stress, abnormal disulfide bonding can occur, leading to aggregation of damaged crystallin proteins, loss of transparency, and cataract formation—the most common cause of human blindness worldwide[3][5]. Dynamic disulfide exchange in crystallins, especially in γ-crystallins, is a critical contributor to this process[3][5][7]. Unlike canonical drug targets, **disulfide bonds** are not molecular entities but structural features, and so are not classifiable as therapeutic targets (e.g., receptor, enzyme, transporter). Experimental therapies may attempt to modulate crystallin aggregation by interfering with disulfide exchange or stabilizing crystallin structure, but no drugs directly target these bonds to date[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crystallin (lens protein).